🇺🇸 Adalimumab plus different doses of oral glucocorticosteroid in United States

Adalimumab plus different doses of oral glucocorticosteroid (Adalimumab plus different doses of oral glucocorticosteroid) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Adalimumab plus different doses of oral glucocorticosteroid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Adalimumab plus different doses of oral glucocorticosteroid approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Adalimumab plus different doses of oral glucocorticosteroid in United States?

Peking Union Medical College Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.